Navigation Links
Mylan Launches First Generic Version of Teveten® Tablets
Date:12/27/2011

PITTSBURGH, Dec. 27, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base). This product is the generic version of Abbott Laboratories' Teveten® Tablets, which are used to treat hypertension.

Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification to the FDA for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base), and was awarded 180 days of marketing exclusivity. Mylan is shipping this product immediately.

Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base), had U.S. sales of approximately $4.9 million for the 12 months ending Sept. 30, 2011, according to IMS Health.

Currently, Mylan has 170 ANDAs pending FDA approval representing $98.4 billion in annual sales, according to IMS Health. Forty-two of these pending ANDAs are potential first-to-file opportunities, representing $26.8 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... TEMPLE, Texas , March 27, 2015 The ... relocate in April to a 5,000-square-foot building at 1802 South ... a geographic area designated by the City of ... Baylor Scott & White and the Central Texas Veterans Health ... office and laboratory space to early stage biotechnology and life ...
(Date:3/27/2015)... March 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... ® Complete Knee System. ... th year since Zimmer first introduced the NexGen knee ... date, more than five million implantations of the NexGen knee ... the NexGen knee demonstrates the importance of design innovation and ...
(Date:3/27/2015)... , March 27, 2015 CHINA ... Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, second ... service industry, will be held at Shanghai New International ... 25 February, 2015,  Implementation Suggestions on Encouraging Private Capital ... which was jointly issued by the Ministry of Civil ...
Breaking Medicine Technology:Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... N.J., Jan. 3, 2012  Ikaria, Inc., a critical care ... critically ill patients in the hospital and ICU settings, ... program, the PRESERVATION I clinical trial, for its Bioabsorbable ... commenced in Australia, and will be followed in Europe.  ...
... 3, 2012 Reportlinker.com announces that a ... its catalogue: Transdermal Drug ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal drug ...
Cached Medicine Technology:Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 2Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 3Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple teams ... according to new research released today at the American Orthopaedic ... “Our findings indicate that a 10 inch increase in height ... history of injury, a 10 mile per hour increase in ... history of injury, and playing for more than one team ...
(Date:3/28/2015)... How best to treat and recover ... orthopaedic medicine. While diagnostic hip injections are commonly performed ... etiology, research presented today at the American Orthopaedic Society ... that pain relief from this diagnostic injection may not ... “Our study looked to assess if the amount of ...
(Date:3/28/2015)... 2015 Early surgery may not be ... AC joint injuries, according to new research from Tripler ... American Orthopaedic Society for Sports Medicine’s ( AOSSM ) ... when surgery was not performed. , The final study ... treatment and 17 receiving non-surgical therapy. Of the non-surgery ...
(Date:3/28/2015)... California (PRWEB) March 28, 2015 Andrew Hawley ... original 1960's Who psychedelic concert posters. The Who and the ... York on August 2, 1968. According to Hawley, “The Who ... many concert halls and college campuses. Perhaps the most famous ... with Jim Morrison and the Doors on August 2, 1968 ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
Breaking Medicine News(10 mins):Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... TORRANCE (May 21, 2008) The American ... has recognized Marianne Gausche-Hill, M.D., FACEP, and Robert ... an honor the organization bestows upon emergency physicians ... their communities and their patients. , The ...
... for a lengthy period provided researcher Suzanne Nooij with ... and disorientation experienced by many astronauts. Nooij defended her ... Technology (TU Delft, The Netherlands) on Tuesday 20 May. ... orientation. Changes in gravitational forces, such as the transition ...
... Decision Making, INDIANAPOLIS, May 21 Eli Lilly ... its executive leadership,structure as the company continues to position ... "Earlier this year I asked each of our ... determine if they were optimally structured to,meet the demands ...
... WASHINGTON, May 21 Secretary of Veterans,Affairs Dr. James ... two special panels that will make recommendations on ways ... in suicide prevention,suicide research and suicide education., "There ... of even one of,the great men or women who ...
... Inc. (OTC,Bulletin Board: MMGP) reported on May 20, 2008, in ... income of $2,019,862 for,the quarter ending March 31, 2008, which ... the same time period last year, the Company,reported income of ... 31, 2008 and 2007 were,$685,663 and $247,954, respectively. The increase ...
... ... ... Waste to Energy, BEIJING and LAS VEGAS, May 21 /Xinhua-PRNewswire-FirstCall/ ... company, and its subsidiaries that engage in multiple,China-focused business activities including ...
Cached Medicine News:Health News:2 LA BioMed researchers named Heroes of Emergency Medicine 2Health News:Why do astronauts suffer from space sickness? 2Health News:Lilly Announces Changes in Key Leadership Roles 2Health News:Lilly Announces Changes in Key Leadership Roles 3Health News:Lilly Announces Changes in Key Leadership Roles 4Health News:Lilly Announces Changes in Key Leadership Roles 5Health News:VA Secretary Appoints Panel of National Suicide Experts 2Health News:MM2 Group Reports Record Net Income of $2,019,862 for Quarter Ending March 31, 2008 2Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 2Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 3Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 4Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 5Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 6Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 7Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 8Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 9Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 10
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
10" overall length, 5" handle....
...
Medicine Products: